Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial

Jin, Hua; Zhang, Yu; Yu, Sijian; Du, Xin; Xu, Na; Shao, Ruoyang; Lin, Dongjun; Chen, Yanqiu; Xiao, Jie; Sun, Zhiqiang; Deng, Lan; Liang, Xinquan; Zhang, Hongyu; Guo, Ziwen; Dai, Min; Shi, Pengcheng; Huang, Fen; Fan, Zhiping; Yin, Zhao; Xuan, Li; Lin, Ren; Jiang, Xuejie; Yu, Guopan; Liu, Qifa

doi:10.1186/s13045-023-01437-1

Journal of Hematology & Oncology

Article metrics
Last updated: Tue, 23 Apr 2024 16:27:54 Z

Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial

Access & Citations

4910

Article Accesses
3

Web of Science
14

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1756-8722

Contact us

General enquiries: journalsubmissions@springernature.com